#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18948	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2788	824.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1795	1795	C	1232	C,T	1230,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32478	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4192	967.4	0	.	n	.	0	T695C	SNP	695	695	T	1283	1283	C	1166	C,G,A	1163,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32478	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4192	967.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1925	1925	A	1357	A,G	1356,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32478	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4192	967.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2559	2559	C	1141	C,T	1139,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32478	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4192	967.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2633	2633	A	1021	A,G	1019,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32478	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4192	967.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3185	3185	C	1162	C,G,A	1160,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2742	folP	852	852	100.0	folP.l15.c4.ctg.1	2013	169.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1272	1274	AGC	273;277;277	A,C;G,A;C	272,1;276,1;277	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6682	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3987	209.3	1	SNP	p	S91F	0	.	.	271	273	TCC	869	871	TCC	251;253;255	T;C;C	251;253;255	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6682	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3987	209.3	1	SNP	p	D95N	0	.	.	283	285	GAC	881	883	GAC	263;265;266	G,C;A;C	262,1;265;266	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6682	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3987	209.3	1	SNP	p	D95G	0	.	.	283	285	GAC	881	883	GAC	263;265;266	G,C;A;C	262,1;265;266	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2540	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1903	166.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	784	786	ACC	244;244;245	A,G;C,A;C	243,1;243,1;245	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2540	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1903	166.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	799	801	CAC	238;242;242	C;A;C	238;242;242	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2540	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1903	166.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	982	984	CAC	354;352;353	C;A;C	354;352;353	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2540	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1903	166.6	1	SNP	p	G45D	0	.	.	133	135	GGC	802	804	GGC	244;245;245	G;G,T;C	244;244,1;245	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1482	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1632	113.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6272	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3550	220.7	1	SNP	p	D86N	0	.	.	256	258	GAC	837	839	GAC	255;256;256	G;A,C;C	255;255,1;256	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6272	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3550	220.7	1	SNP	p	S87R	0	.	.	259	261	AGT	840	842	AGT	253;255;255	A;G;T	253;255;255	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6272	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3550	220.7	1	SNP	p	S87W	0	.	.	259	261	AGT	840	842	AGT	253;255;255	A;G;T	253;255;255	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6272	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3550	220.7	1	SNP	p	S87I	0	.	.	259	261	AGT	840	842	AGT	253;255;255	A;G;T	253;255;255	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6272	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3550	220.7	1	SNP	p	S88P	0	.	.	262	264	TCC	843	845	TCC	258;256;255	T;C;C,G	258;256;254,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5504	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3108	220.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1737	1739	GGC	333;333;332	G;G;C,A	333;333;330,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1538	1540	GCA	284;285;281	G,A;C;A	283,1;285;281	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1541	1543	ATC	281;280;281	A;T,C;C	281;279,1;281	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1553	1555	GTG	269;271;270	G;T;G	269;271;270	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1553	1555	GTG	269;271;270	G;T;G	269;271;270	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2057	2059	ACC	261;261;264	A;C;C	261;261;264	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2111	2113	GCG	268;269;266	G;C;G,C	268;269;265,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2111	2113	GCG	268;269;266	G;C;G,C	268;269;265,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2234	2236	GGT	311;309;309	G;G,A;T	311;308,1;309	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2243	2245	GGC	312;310;307	G;G;C	312;310;307	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5000	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3007	207.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2261	2263	CCG	301;302;301	C;C;G	301;302;301	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6966	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3656	237.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3316	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2300	179.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	813	813	C	274	C,G	273,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	360	porB1a	984	186	93.55	porB1a.l15.c17.ctg.1	186	64.5	0	.	p	.	0	A251V	NONSYN	751	753	GCG	24	26	GTA	27;27;28	G;T;A	27;27;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	360	porB1a	984	186	93.55	porB1a.l15.c17.ctg.1	186	64.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	84	86	ACT	96;96;96	A;C;T	96;96;96	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	360	porB1a	984	186	93.55	porB1a.l15.c17.ctg.1	186	64.5	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	90	92	GAT	96;96;96	G;A;T	96;96;96	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	360	porB1a	984	186	93.55	porB1a.l15.c17.ctg.1	186	64.5	0	.	p	.	0	D276N	NONSYN	826	828	GAT	99	101	AAC	96;96;96	A;A;C	96;96;96	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	360	porB1a	984	186	93.55	porB1a.l15.c17.ctg.1	186	64.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	102	104	CAC	96;96;96	C;A;C	96;96;96	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	688	690	GTT	332;329;329	G,T;T;T	331,1;329;329	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	0	.	p	.	0	I75V	NONSYN	223	225	ATT	778	780	GTT	342;343;342	G;T;T,C	342;343;341,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	0	.	p	.	0	S89T	NONSYN	265	267	AGC	820	822	ACC	326;328;326	A,C;C;C,T,A	325,1;328;322,2,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	0	.	p	.	0	I98V	NONSYN	292	294	ATC	847	849	GTC	300;303;304	G;T,G;C	300;302,1;304	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1204	1206	GGT	325;317;313	G;G,T;T	325;316,1;313	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	1	SNP	p	G120K	1	.	.	358	360	AAG	913	915	AAG	284;286;283	A;A;G	284;286;283	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	1	SNP	p	N121D	0	.	.	361	363	AAC	916	918	AAC	284;285;284	A,G;A;C	283,1;285;284	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3804	porB1b	1038	1038	99.33	porB1b.l6.c17.ctg.1	1845	256.3	1	SNP	p	A121N	1	.	.	361	363	AAC	916	918	AAC	284;285;284	A,G;A;C	283,1;285;284	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12052	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5439	276.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2313	2315	AAT	312;312;312	A;A;T	312;312;312	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1592	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1559	127.5	1	SNP	p	V57M	1	.	.	169	171	ATG	788	790	ATG	299;299;302	A,T;T,G;G,T	298,1;298,1;301,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
